An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy

<p>Abstract</p> <p>Background</p> <p>Overexpression of Fra-1 in fibroblasts causes anchorage-independent cell growth and oncogenic transformation. A high level of Fra-1 expression is found in various tumors and tumorigenic cell lines, suggesting that Fra-1 may be involv...

Full description

Bibliographic Details
Main Authors: Chen Liyong, Zhang Yan, Zhang Dong, Song Santai, Song Yuhua, Qian Lu, Shi Ming, Zhao Huibin, Jiang Zefei, Guo Ning
Format: Article
Language:English
Published: BMC 2006-12-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/6/298
_version_ 1818144873490939904
author Chen Liyong
Zhang Yan
Zhang Dong
Song Santai
Song Yuhua
Qian Lu
Shi Ming
Zhao Huibin
Jiang Zefei
Guo Ning
author_facet Chen Liyong
Zhang Yan
Zhang Dong
Song Santai
Song Yuhua
Qian Lu
Shi Ming
Zhao Huibin
Jiang Zefei
Guo Ning
author_sort Chen Liyong
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Overexpression of Fra-1 in fibroblasts causes anchorage-independent cell growth and oncogenic transformation. A high level of Fra-1 expression is found in various tumors and tumorigenic cell lines, suggesting that Fra-1 may be involved in malignant progression. This study aimed to investigate the significance of Fra-1 expression in breast carcinogenesis.</p> <p>Methods</p> <p>The expression of Fra-1 was investigated by immunohistochemistry in neoplastic breast diseases ranging from benign fibroadenoma to very aggressive undifferentiated carcinoma. The correlations of Fra-1 expression with other indicators of breast carcinoma prognosis (ER, PR and ErbB2 receptors) were analyzed.</p> <p>Results</p> <p>All neoplastic breast tissues, either benign or malignant breast tissues, were nuclear immunoreactive for Fra-1-recognizing antibody. The pattern of Fra-1 expression by benign neoplastic cells was predominantly nuclear. However, the nuclear/cytoplasmic concomitant immunoreactivity was observed in all types of breast carcinomas. A clear shift in Fra-1 immunoreactivity, from an exclusively nuclear to a simultaneous nuclear and cytoplasmic localization was noticed in ~90% of breast carcinomas.</p> <p>Conclusion</p> <p>The overall expression, pattern and intensity of Fra-1 proteins were correlated with breast oncogenesis. Overexpression of Fra-1, leading to a persistent high cytoplasmic accumulation, may play a role in the process of breast carcinogenesis.</p>
first_indexed 2024-12-11T11:54:29Z
format Article
id doaj.art-d3852399ca9e41c1b4488ee9a4f8671a
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T11:54:29Z
publishDate 2006-12-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-d3852399ca9e41c1b4488ee9a4f8671a2022-12-22T01:08:16ZengBMCBMC Cancer1471-24072006-12-016129810.1186/1471-2407-6-298An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancyChen LiyongZhang YanZhang DongSong SantaiSong YuhuaQian LuShi MingZhao HuibinJiang ZefeiGuo Ning<p>Abstract</p> <p>Background</p> <p>Overexpression of Fra-1 in fibroblasts causes anchorage-independent cell growth and oncogenic transformation. A high level of Fra-1 expression is found in various tumors and tumorigenic cell lines, suggesting that Fra-1 may be involved in malignant progression. This study aimed to investigate the significance of Fra-1 expression in breast carcinogenesis.</p> <p>Methods</p> <p>The expression of Fra-1 was investigated by immunohistochemistry in neoplastic breast diseases ranging from benign fibroadenoma to very aggressive undifferentiated carcinoma. The correlations of Fra-1 expression with other indicators of breast carcinoma prognosis (ER, PR and ErbB2 receptors) were analyzed.</p> <p>Results</p> <p>All neoplastic breast tissues, either benign or malignant breast tissues, were nuclear immunoreactive for Fra-1-recognizing antibody. The pattern of Fra-1 expression by benign neoplastic cells was predominantly nuclear. However, the nuclear/cytoplasmic concomitant immunoreactivity was observed in all types of breast carcinomas. A clear shift in Fra-1 immunoreactivity, from an exclusively nuclear to a simultaneous nuclear and cytoplasmic localization was noticed in ~90% of breast carcinomas.</p> <p>Conclusion</p> <p>The overall expression, pattern and intensity of Fra-1 proteins were correlated with breast oncogenesis. Overexpression of Fra-1, leading to a persistent high cytoplasmic accumulation, may play a role in the process of breast carcinogenesis.</p>http://www.biomedcentral.com/1471-2407/6/298
spellingShingle Chen Liyong
Zhang Yan
Zhang Dong
Song Santai
Song Yuhua
Qian Lu
Shi Ming
Zhao Huibin
Jiang Zefei
Guo Ning
An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
BMC Cancer
title An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
title_full An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
title_fullStr An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
title_full_unstemmed An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
title_short An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy
title_sort association of a simultaneous nuclear and cytoplasmic localization of fra 1 with breast malignancy
url http://www.biomedcentral.com/1471-2407/6/298
work_keys_str_mv AT chenliyong anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhangyan anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhangdong anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT songsantai anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT songyuhua anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT qianlu anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT shiming anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhaohuibin anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT jiangzefei anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT guoning anassociationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT chenliyong associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhangyan associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhangdong associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT songsantai associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT songyuhua associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT qianlu associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT shiming associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT zhaohuibin associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT jiangzefei associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy
AT guoning associationofasimultaneousnuclearandcytoplasmiclocalizationoffra1withbreastmalignancy